Skip to main content

Palmer Online: Obesity Drugs 2025

Tracking # 20-1296805

$24.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

There is an alarming pandemic of obesity in the United States. Big Pharma's expensive "solution" is long-term treatment with modified peptides (e.g. Ozempic, Wegovy, Tirzepatide, Zepbound, Mounjaro, etc.). The longer-lasting drugs are given at concentrations thousands of times greater than normal physiology. The act via the nervous. Recent legislation, H.R.4818 - Treat and Reduce Obesity Act of 2023, clears the way for widespread use in treating obesity. Learn what they are, how they work, and possible ramifications.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Chiropractic Medicine

Chiropractic Physician

1h General (Nutrition)

Georgia Board of Chiropractic Examiners

Chiropractor

1h Nutrition

North Carolina Board of Chiropractic Examiners

Doctor of Chiropractic

1h Chiropractic Continuing Education

Tennessee Board of Chiropractic Examiners

Chiropractic Physician

1h Chiropractic Continuing Education